Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Liver Disease Remove


July 2020
SuSaFrThWeTuMo
1211109876

Public Company News

Business Press Releases

Liver Disease Press Releases

Exclusive News
Topics Locations Industries Dates

By SFA Therapeutics, Inc.
SFA Therapeutics, Inc. announced today that FDA has granted an official Orphan Drug Designation (ODD) to SFA001, the company's novel human-microbiome-based treatment for human hepatocellular carcinoma (HCC).

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share